Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TNG260 |
Trade Name | |
Synonyms | TNG-260|TNG 260 |
Drug Descriptions |
TNG260 inhibits the HDAC1-containing complex CoREST, potentially resulting in increased antitumor immune activity (Cancer Res (2023) 83 (7_Supplement): ND12). |
DrugClasses | HDAC Inhibitor 45 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + TNG260 | Pembrolizumab TNG260 | 0 | 1 |
TNG260 | TNG260 | 0 | 0 |